What Happened
The U.S.
Attorney’s Office for the Southern District of Georgia announced a $4.1 million civil settlement with a Georgia hospital over drug diversion allegations. The government alleged the hospital failed to provide effective controls and procedures to guard against theft and loss of controlled substances, leaving tens of thousands of 30 mg oxycodone tablets unaccounted for and believed diverted over four years, and failed to notify DEA of suspected diversion timely. The hospital agreed to a DEA performance improvement plan including quarterly internal accountability audits and controlled-substance tracking requirements.
What the Record Shows
$4.1 million civil settlement and performance improvement plan with DEA
Why It Matters for Diversion Programs
This entry comes from a news source rather than a federal enforcement release, and it is recorded as reported: allegedly failed to provide effective controls and procedures to guard against theft and loss of controlled substances, resulting in tens of thousands of 30 mg oxycodone tablets unaccounted for and believed diverted for illegal uses over a four-year period, and allegedly failed to notify DEA of suspected diversion within the requisite time period. Board and news records are a lagging indicator - by the time a licensing authority or a reporter learns of a diversion, the diversion was normally detected internally first, which makes each entry a signal that inventory reconciliation, waste observation or dispensing oversight failed earlier.